Why partner with AstraZeneca?

We have a global commercial presence and strength in emerging markets, particularly in China. Our innovative medicines, many of which are developed in partnership with others, are used by millions of patients worldwide.



$26.6bn

Total Revenue

$727m

Collaboration Revenue

120+

major or strategically important deals completed in last three years

800+

collaborations worldwide help us access the best science, stimulate innovation and accelerate delivery of new medicines for unmet medical needs


71,600

employees

26

manufacturing sites in 16 countries

Nearly $6bn

invested in R&D

90%

of pipeline has a precision medicine approach


For year ending 31 December 2020
 


Pushing the boundaries of science to deliver life-changing medicines

Inspired by our values and what science can do, we are focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society.




Encouraging innovation and inspiring the next generation of start-ups



Veeva ID: Z4-32948
Date of Prep: May 2021